About this document

Roche by slinjbiopharm is a document available to read on EtoBox.

Roche is adapting to a more challenging healthcare environment by focusing on operational excellence and continued innovation. The company expects to achieve savings of CHF 2.4 billion by 2012 through restructuring measures across various functions. This will include reducing headcount by 4,800 positions. One-off restructuring costs are estimated at CHF 2.7 billion from 2010 to 2012. Roche is also repaying debt from its Genentech acquisition faster than planned. The company remains on track to achieve its g

Author

slinjbiopharm

Language

EN